Introduction: 30 ± 50% of American women complain of sexual dysfunction. Aging, menopause, and a decline in circulating estrogen levels signi®cantly increase the incidence of sexual complaints. Evaluaton of physiologic components of the female sexual response has, in the past, been technically challenging and dif®cult to standardize. We describe methodology for evaluating physiologic and subjective components of the female sexual response in the clinical setting and determine the effcts of age and estrogen status on them. Methods: 48 women with complaints of sexual dysfunction were evaluated. Physiologic measurements include genital blood peak systolic velocity, vaginal pH, intravaginal pressure ± volume changes (compliance), and genital vibratory perception thresholds. Measurements were recorded at baseline and following sexual stimulation. Baseline subjective sexual function was assessed using a Female Sexual Function Inventory. Age was then correlated with both physiologic and subjective sexual responses. Results: Sexual stimulation resulted in increased mean genital blood peak systolic velocity, vaginal pressure ± volume, and vaginal pH measurements (P`0.05) in all women. Older women (ages 55 ± 71 y) and menopausal women not on hormone replacement therapy had signi®cantly lower physiologic response sexual complaints. Baseline subjective sexual function complaints included low arousal (67%), low desire (21%), dif®culty achieving orgasm (92%), and pain or discomfort during andaor following intercourse (67%). Conclusions: Clinical evaluation of physiologic and subjective components of the female sexual response are possible using this comprehensive approach. Physiologic measurements were reproducible and easy to perform, and incidence and types of sexual complaints were assessed with the sexual function questionnaire. A comprehensive approach is necessary when evaluating female sexual dysfunction due to the signi®cant emotional and relational factors that can contribute to the problem. This combined subjectiveaphysiologic assessment may also prove useful when evaluating ef®cacy of pharmacotherapy in the future.
Introduction
During female sexual arousal, sensory stimulation leads to central nervous system activation resulting in vaginal and clitoral smooth muscle relaxation and increased genital blood¯ow. This culminates in a series of vasocongestive and neuromuscular events, which include increased clitoral and vaginal length and diameter, increased vaginal lubrication and wall engorgement. 1 ± 3 This study describes effective means for assessing physiologic and subjective components of the female sexual response in the clinical setting. The effects of age and estrogen status on both the physiologic and subjective components of the female sexual response will also be addressed.
With aging and menopause, a majority of women experience some change in sexual function. Common sexual complaints include loss of desire, decreased frequency of sexual activity, painful intercourse, diminished sexual responsiveness, dif®culty achieving orgasm, and decreased genital sensation. Symptoms related to alterations in genital sensation and blood¯ow are, in part, secondary to declining estrogen levels, and there is a direct correlation between the presence of sexual complaints and levels of estradiol below 50 pgacc. Symptoms markedly decrease with estrogen replacement. 2 Similar to the impact of natural menopause, surgical menopause brought on by hysterectomya oophorectomy has signi®cant negative impacts on sexual function. Even hysterectomy alone, without the removal of the ovaries, can result in sexual dysfunction. 4 Symptoms women commonly experience post-operatively include decreased desire, decreased arousal, decreased genital sensation and orgasmic dysfunction. The anatomicaphysiologic basis for sexual dysfunction post-hysterectomy is still unclear. At present, we have limited understanding of the female neurovascular anatomy vital to normal sexual arousal and function. This is an area of focus and research in our laboratory, and in the future, we hope to provide women with nervesparing pelvic procedures similar to those now routinely performed in men.
Female sexual complaints are often not purely psychologically based. In fact, the same medical problems that cause erectile dysfunction in men, such as diabetes, high blood pressure, high cholesterol levels, etc., may also result in sexual dysfunction in women. For example, the recently named vaginal and clitoral erectile insuf®ciency syndromes are, in fact, directly related to diminished genital blood¯ow. 3 Diminished pelvic blood¯ow secondary to aorto-iliac or atherosclerotic disease leads to vaginal wall and clitoral smooth muscle ®brosis. 5 Histomorphometric evaluaton of clitoral erectile tissue from atherosclerotic animals demonstrates cavernosal artery wall thickening, loss of corporal smooth muscle and an increase in collagen deposition. In human clitoral tissue, there is a loss of corporal smooth muscle, replacement by ®brous connective tissue in associaton with atherosclerosis of clitoral cavernosal arteries. 6 Any traumatic injury to the iliohypogastric pudendal arterial bed from pelvic fractures, blunt trauma, surgical disruption, or chronic perineal pressure from bicycle riding for instance, can result in diminished vaginal and clitoral blood¯ow and complaints of sexual dysfunction.
Although other underlying conditons, either psychological or physiological, may manifest as decreased vaginal and clitoral engorgement, arterial insuf®ciency is one etiology that should be considered.
In the clinical setting, female sexual responses have been dif®cult to quantify objectively. The changes that occur with female sexual arousal are not only dif®cult to measure, but are also not always recognized by the patient. Previously described techniques for evaluating physiologic changes during female sexual arousal include estimates of vaginal engorgement, labial and vaginal temperature changes, and pelvic contractions with orgasm. 7 Vaginal photoplethysmography is the most used and validated estimate of vaginal blood¯ow, or more speci®cally, engorgement. This method, however, is subject to movement artifact and is thus not suitable for studying the patient during masturbationastimulation. In addition, it provides arbitrary rather than absolute units of measurement and no anatomic information is provided. 7 We use duplex Doppler ultrasonography to assess changes in female genital hemodynamics during sexual arousal. This technique provides continuous, realtime imaging of anatomic, as well as vasocongestive (engorgement) components of the female sexual response. In additon, it records blood velocity in absolute units; centimeters per second (cmas).
In addition to documenting genital blood velocity, we also measure changes in vaginal lubrication, vaginal elasticity or compliance, as well as genital sensation. Information obtained from these physiologic measurements helps to clarify the etiology of an organically based sexual dysfunction, and may lead to improved diganostic and evaluative techniques for female sexual complaints. Furthermore, development of reliable methodology as well as establishment of treatment outcomes will allow us, in the future, to effectively evaluate the effects of drug therapies.
To assess subjective sexual function, in particular sexual arousal, few instruments have been validated. We use the Brief Index of Sexual Function Inventory (BISF-W), which is a 21-item self-report inventory of sexual interest, activity, satisfaction and preference. This instrument has been validated and found to be highly reliable and to discriminate between depressed and sexually dysfunctional healthy patients. 8, 9 Subjective sexual response data re¯ect the personal experience of the patient. This is an important variable to evaluate because our ultimate goal is to enhance the personal sexual experience of the woman. The intervention is not considered successful unless the woman is able to subjectively experience sexual arousal, pleasure and satisfaction. Thus, it is important to determine if physiological changes or improvement in blood ow, translates into an improved sexual experience. For instance, a physiologically documented increase in blood¯ow and pH is irrelevant, unless the patient actually experiences increased arousal, sensation, and satisfaction that re¯ects those physiological processes.
Materials and methods
Following Institutional Review Board approval, 48 women who presented to the Women's Sexual Health Clinic with complaints of sexual dysfunction were evaluated. A psychosocial, as well as full medical exam was performed on each patient.
Each patient had physiologic measurements recorded at baseline and following sexual stimulation using a 15-min standardized erotic video (Sinclair Institute, Femme Productions, Chapel Hill, NC) and vibrator (Ferticare, ITLS, Inc., Evans, CA). Visual stimulation was maintained throughout the entire evaluation using 3-D surround sound glasses (I.O. The physiologic parameters evaluated included genital blood peak systolic velocity, vaginal pH, vaginal pressureavolume (compliance) changes, and genital vibratory perception thresholds. Clitoral, labial (vestibular bulb), urethral, and vaginal arterial peak systolic velocity and end diastolic velocity is measured using duplex Doppler ultrasonography (General Electric Logic 400, MA). A 12 mHz probe was used externally to measure right and left clitoral cavernosal, as well as right and left labial and urethral arterial blood¯ow. Urethral measurements were recorded on the ventral surface. The largest branch on either the right or left side was recorded. Labial measurements were recorded from the posterior labialabulbar artery. The vestibular bulb is located directly beneath the skin of the labia minora. A transvaginal probe was used to measure right and left vaginal arterial blood¯ow. The mean of three consecutive measurements was recorded for each site.
Vaginal pH was measured with a digital pH meter (Sandhill, Inc., Highlands Ranch, CO). The probe was inserted into the vagina and the mean of consecutive measurements was recorded.
Vaginal pressureavolume (compliance) changes were measured with a commercially available compliance balloon (Schuster Balloon, Sandhill, Inc.).
Measurements were recorded at 0 cc and then following 30 cc increments of air instillation. Maximum vaginal pressureavolume (compliance) was de®ned as the intravaginal pressure at maximum intravaginal volume. The maximum volume was determined when the patient experienced vaginal pressure or fullness that was uncomfortable, but not painful.
Vibratory perception thresholds were recorded from the clitoris (dorsal midline) and right and left labia minora using a standard biothesiometer. The mean of three measurements was recorded for each site.
All 48 patients completed the Brief Index of Sexual Function Inventory (BISF-W) prior to the medial, physiological, orpsychosocial evaluations. Demographic information including age, menopausal and estrogen status, and past medical and surgical history were also recorded.
Statistical analysis
Changes in mean pre-to post-stimulation physiologic measurements were evaluated using a paired ttest. Comparisons between groups of women (young to old, and menopausal with HRT to menopausal without HRT) were performed using an unpaired ttest, and P-values 0.05 were considered statistically signi®cant. For subjective sexual function complaints, trends, in terms of percentages, were established. Menopausal status (with or without hormone replacement therapy) was then correlated with subjective sexual complaints using a two-tail Fisher's exact test.
Results
The physiologic and subjective sexual response data from 48 women, (mean age 45.7 y AE 10.8) was evaluated. All women had complaints of sexual dysfunction including, but not limited to, sexual arousal disorder, hypoactive sexual desire disorder, and orgasmic disorder ( Table 1) .
A total of 45.8% of women (n 22) were menopausal (no spontaneous menstruation for greater than six months or FSH levels b 40 ng and estradiol levels`20 ng). Of these menopausal women, 59% (n 13) were receiving HRT. Patients were not categorized by type of HRT.
Physiologic measurements: clitoral, labial, urethral and vaginal artery peak systolic (PSV) and end diastolic velocities (EDV):
Sexual stimulation resulted in signi®cant increases in genital blood velocity in all patients (48a48). Following sexual stimulation, mean clitoral peak systolic velocity and end diastolic velocities signi®cantly increased. Mean right and left vestibular bulb (labial) peak systolic and end diastolic velocities also signi®cantly inceased. Mean urethral and right and left vaginal arterial peak systolic velocity and end diastolic velocity signi®cantly increased (Table 2 ).
In the menopausal group, women receiving HRT had higher pre-and post-stimulation vaginal, clitoral, urethral and labial blood velocity than menopausal women not receiving HRT; however, these differences were not signi®cant. When analyzed by age, older women (ages 55 ± 67 y) had signi®cantly lower pre-stimulation clitoral, labial, urethral and vaginal blood velocities than younger women (ages 25 ± 54 y) (P 0.048, 0.027, 0.030 and 0.050, respectively). Post-stimulation, there were no signi®cant differences in genital blood velocity between younger and older women (Table 3) .
Vaginal pH
Mean pH measurements signi®cantly increased following sexual stimulation from a mean baseline value of 5.68 to a mean post-stimulaton value of 6.16 in all 48 women. In the menopausal group (n 22), women receiving HRT (n 13) had signi®cantly lower baseline vaginal pHs than those who were not (n 9) (P`0.05). Post-stimulation, vaginal pH measurements signi®cantly increased in menopausal women receiving HRT. Although there was an increase in post-stimulation pH measurements from menopausal women not receiving HRT, the changes were not signi®cant. There was no signi®cant difference between pre-or post-stimulaton vaginal pHs between younger women (ages 25 ± 54 y) and older women (ages 55 ± 67 y) ( Table 4) .
Vaginal pressure ± volume changes (compliance)
Sexual stimulation resulted in signi®cant increases in maximum vaginal compliance (P 0.003) in all patients. In the menopausal group (n 22), women receiving HRT (n 13) had higher maximum vaginal pressure ± volume measurements (190cm 3 ) than those who were not (120 cm 3 n 9). In addition, younger women (ages 25 ± 54 y) had higher maximum pressure ± volume measurements than older women (ages 55 ± 67 y); however these differences were not statistically signi®cant (Table 5) .
Vibratory perception thresholds
In all women, sexual stimulaton resulted in decreased clitoral and labial vibratory perception thresholds; however, these changes were not statis- 6.14 AE 1.14* 6.79 AE 1.06 *Statistically signi®cant increase in pH, pre-to post-stimulation at the P`0.05 level.
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Discussion
The female sexual response has been dif®cult to quantify and evaluate clinically. In the past, instruments to measure female sexual responses have been technically limited, and were often not reproducible or reliable. The techniques described in this study, which utilize current medical technologies, are being validated and compared to previously described techniques. New female sexual function questionnaires, speci®c for arousal disorder, are also being developed and validated. We describe a comprehensive subjective and physiologic approach to evaluate the female sexual response in the clinical setting. Using this combined approach, we documented changes in physiologic parameters of the female sexual response, determined trends for female sexual complaints, and correlated them with risk factors, in particular increasing age. In the future, this methodology can be used to determine baseline female sexual function following speci®c treatments.
Despite subjective complaints of decreased sexual arousal, sexual stimulaton resulted in signi®cant physiologic responses in these women. The explanation for this phenomenon is two-fold. First, women are often not cognizant of their level of arousal (i.e. the amount of lubrication or genital swelling) or the physiologic changes that are occurring, but rather know more subjectively how they`feel'. 10 Secondly, it is also possible that emotionalapsychological issues interfere with the patient's subjective sexual experience. This suggests that in the future, subjective questionnaires should be included in the evaluation of female sexual function. Furthermore, the emotional aspects and the context in which a woman experiences her sexuality are equal, if not more important than the physiologic outcome. For this reason, we suggest that all women with complaints of sexual dysfunction undergo a psychosocial evaluation to determine the emotionalarelational components that may be contributing to the problem. If there are signi®cant interpersonal or relational issues in women, pharmacotherapy is not the sole solution to the problem. This differs in some ways from the treatment of psychogenic male erectile dysfunction for which pharmacotherapy is 85 ± 90% effective.
It is also possible that sexual responses that occurred in these women, although signi®cant, were not suf®cient enough for the patient to subjectively notice a difference. Normative data is being gathered for comparison to determine what the normal physiologic responses are for women in different age groups.
Changes in vaginal pH
With sexual stimulation, a transudate develops from vaginal mucosal epithelial cells, and secretions are released from the cervix. The transudate occurs as a result of increased blood¯ow to the vagina and increased hydrostatic pressure within the capillaries of the vaginal wall. Vaginal pH subsequently increases, approaching values of 6.5 ± 7.8. This increase in vaginal pH, with sexual arousal, is believed to promote sperm capacitance and survival, which ordinarily cannot survive in the acidic pH of the unaroused vagina. Attempts to measure vaginal pH, as an indirect measurement of vaginal lubrication, have in the past been technically dif®cult, intrusive and with con¯icting reports. One study showed that sexual arousal can induce changes in the surface pH of one part of the vagina while not affecting the other. 11 In addition, the estrogen status of the woman, as well as local bacterial¯ora can effect vaginal pH.
We established a highly sensitive means for measuring changes in vaginal pH using a soft, 1 cm probe. In this study, vaginal pH signi®cantly increased with sexual stimulation. Menopausal women receiving HRT had signi®cantly lower baseline vaginal pH levels than those who were not (5.12 vs 6.14; P`0.05). This technique may prove useful in the evaluaion of changes in vaginal pH following vasoactive drug treatment. In addition, baseline information prior to implementing HRT or other treatment can be obtained.
Changes in genital blood velocity
Sexual arousal and stimulaton results in increased blood¯ow to the hypogastricapudendal arterial bed. This leads to increased perfusion to the sexual organs, speci®cally the vagina, clitoris, labia and urethra. Using duplex Doppler ultrasound, we documented signi®cant increases in blood velocity to these structures. With sexual stimulation and arousal, in addition to increased genital blood velocity, there is also concomitant smooth muscle relaxation of clitoral and vestibular bulb erectile tisue. 3 This results in an increase in length and diameter of the clitoris, as well as engorgement of the clitoris and labia. Following sexual stimulation, Older women (ages 55 ± 67 y; n 12) had signi®-cantly lower baseline vaginal, clitoral, urethral, and labial blood velocities (PSV and EDV) than younger women (ages 25 ± 54 y; n 36). These ®ndings correspond to those in aging men that demonstrated decreased cavernosal arterial in¯ow on duplex ultrasound, as well as increased incidence of erectile dysfunction. Within the menopausal group (n 22), women receiving HRT (n 13) had signi®-cantly higher baseline blood velocities than those who were not (n 9). There were no signi®cant differences in post-stimulation blood velocity measurements in the menopausal group. These ®ndings correspond with those of Lann and Everaerd 10 who demonstrated with photoplethysmography, that baseline vaginal blood¯ow in menopausal and postmenopausal women was lower in premenopausal women, but that with sexual stimulation, no signi®cant differences occurred between premenopausal women and untreated menopausal women or postmenopausal women.
Enhanced pelvic blood¯ow with estrogen has been correlated with increased vaginal secretions, decrease in dyspareunia, increased clitoral sensation, orgasmic response and libido. 12 In this study, post-stimulation blood velocity in women not receiving hormone replacement therapy was similar to those who were receiving HRT. This may be secondary to a compensatory or`reserve' mechanism. Nonetheless, the women without HRT have persistent baseline vaginal mucosal atrophy and dryness, despite adequate blood velocity responses to sexual stimulation. Further research in this area is needed to determine the role of hormones on the female sexual response.
Vaginal pressure ± volume (compliance) changes
With sexual stimulaton, relaxation of vaginal smooth muscle occurs, resulting in increased length and luminal diameter of the vagina. 1 This was documented using vaginal pressure ± volume measurements. Sexual stimulation resulted in signi®cant increases in vaginal pressure ± volume. In the postmenopausal group (n 22), women not receiving HRT (n 9) had lower pre-and post-stimulaton maximum vaginal compliance measurements than those who were on HRT (n 13). In addition, older women had lower maximum compliance measurements (c 127.5 cm 3 ) than younger women (159 cm 3 ).
Aging and menopause and the concomitant decrease in circulating estrogen levels leads to atrophy of vaginal wall smooth muscle with secondary vaginal wall ®brosis and collagen deposition. This results in diminished vaginal engorgement and smooth muscle relaxation in response to sexual stimulation. Vaginal pressure ± volume measurements appear to provide information about the ability of the vagina to relax and dilate with sexual stimulation. In addition, baseline information can be obtained prior to implementing HRT in postmenopausal women with dyspareunia secondary to vaginal muscle atrophy and vaginal wall ®brosis.
Changes in vibratory perception thresholds
Vibratory thresholds provide information about the level of sensation in the genital tissue. Somatic sensory pathways originate from clitoral skin. There is a dense collection of Paccinian corpuscles innervated by rapidly adapting myelinated afferents, as well as Meissner's corpuscles, Merckel tactile discs, and free nerve endings. These sensory afferents pass from the dorsal slitoral nerve to the pudendal nerve. The primary receptors for vibratory sensation are the Paccinian and Meissner's corpuscles.
In this study, there was a modest decrease in clitoral and labial vibratory thresholds following sexual stimulation, however the change was not found to be statistically signi®cant. Despite the wellknown effect of estrogen on enhancing genital sensation, there was no difference in pre-or poststimulation vibratory perception thresholds between women receiving HRT and those who were not, or between younger women and older women. This is contrary to the literature in men, which has demonstrated increasing penile vibratory thresholds with age. 13 Nonetheless, this is a population of women with sexual dysfunction, therefore normative data is needed for comparison.
The usefulness of this information obtained poststimulation is questionable, especially once a vibrator had been used for a prolonged period of time, resulting in desensitization of the sensory receptors. More involved techniques such as somatosensory evoked potentials and pudendal nerve latencies are useful to obtain baseline information, and may be required for complicated cases. They are, however, dif®cult to use as part of the routine sexual response evaluation.
Conclusions
Using this approach, documentation of signi®cant increases in physiologic parameters of the female Clinical evaluation of female sexual function JR Berman et al S37 sexual response were possible. These evaluations are non-invasive, easy to perform, and the presence of an examiner in the room does not appear to interfere with the evaluation or the results.
Evaluating the female sexual response in the clinical setting helps to validate the patient's problem and potentially diagnose organic disease processes such as vascular insuf®ciency or neurologic injury. For biofeedback purposes, the patient can also visualize and hear changes in her genital blood¯ow and receive information regarding the physiologic basis of her problem.
Nonetheless, despite the presence of organic disease, there are often psychological, emotional andaor relational factors that contribute to female sexual dysfunction. For this reason, a comprehensive approach, addressing both the psychosocial as well as the medicalaphysiologic factors is instrumental to the evaluation and treatment of female patients with sexual complaints.
In the future, evaluation of the effect of drug therapies on both subjective and objective parameters of the female sexual response will be possible using a comprehensive psychological and physiological approach, such as this. The evaluation should also include a complete medical and psychosocial evaluation, as well as inclusion of the partner or spouse in the evaluation and treatment process. Although there are signi®cant anatomical and embryological parallels between men and women, the female sexual response is clearly multifaceted and distinct from that of the male. Thus, we cannot approach female patients, or their sexual function problems, in a similar fashion as male patients. The context in which a woman experiences her sexuality is equally if not more important than the physiologic outcome, and these emotionalarelational issues need to be addressed prior to beginning medical therapies or attempting to determine treatment ef®cacies. At present, increasing numbers of women are utilizing`off-label' vasoactive medications, approved for the treatment of male erectile dysfunction. The growing use of these agents by women supports the need for more basic science and physiologic research in this area.
